Your browser doesn't support javascript.
loading
Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients.
Caro, Jessica; Madero-Marroquin, Rafael; Zubizarreta, Nicole; Moshier, Erin; Tremblay, Douglas; Coltoff, Alex; Lancman, Guido; Fuller, Risa; Rana, Meenakshi; Mascarenhas, John; Jacobs, Samantha E.
Afiliação
  • Caro J; Monter Cancer Center, Northwell Health, Lake Success, NY. Electronic address: jcaro3@northwell.edu.
  • Madero-Marroquin R; Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and Mount Sinai West, New York, NY.
  • Zubizarreta N; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Moshier E; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Tremblay D; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Coltoff A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Lancman G; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Fuller R; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Rana M; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Jacobs SE; Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Clin Lymphoma Myeloma Leuk ; 22(12): 903-911, 2022 12.
Article em En | MEDLINE | ID: mdl-36109322
ABSTRACT

INTRODUCTION:

Fluoroquinolone prophylaxis is recommended during induction chemotherapy for patients with acute myeloid leukemia (AML) to reduce risk of neutropenic fever and systemic bacterial infections. We evaluated the effectiveness of primary fluoroquinolone prophylaxis in an area with high fluoroquinolone resistance. MATERIALS AND

METHODS:

We performed a retrospective chart review of newly diagnosed adult AML patients who received frontline therapy at Mount Sinai Hospital in New York, NY, between 2012 and 2019. Primary outcome was development of neutropenic fever. Secondary outcomes were development of systemic bacterial infections and infections with multidrug-resistant organisms and Clostridioides difficile. Infectious outcomes were collected through 6 months after therapy initiation. We estimated the effect of fluoroquinolone prophylaxis with a time-dependent Cox proportional hazards model.

RESULTS:

Of 121 included patients, 87 received antibiotic prophylaxis and 34 did not. There was no difference in baseline characteristics, although the prophylaxis group had longer neutropenia duration (median 30 vs. 23 days, P = .013). The prophylaxis group had a reduced risk of neutropenic fever (hazard ratio 0.59, P = .039). The prophylaxis group had fewer gram-positive (P = .043) and gram-negative (P = .049) bloodstream infections and fewer clinically documented infections during frontline therapy (P = .005) and follow-up (P = .026). There was no difference in incidence of C. difficile or infection with fluoroquinolone-resistant or multidrug-resistant organisms. There was no mortality difference between groups.

CONCLUSION:

In an area with high fluoroquinolone resistance, primary fluoroquinolone prophylaxis in newly diagnosed AML patients reduced the risk of neutropenic fever and systemic bacterial infections without increased antimicrobial resistance. Prospective, randomized studies are needed to confirm these observations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Leucemia Mieloide Aguda / Clostridioides difficile Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Bacterianas / Leucemia Mieloide Aguda / Clostridioides difficile Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article